Fabienne Mauxion
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fabienne Mauxion has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Bertrand Séraphin
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
13 shared publications R Sen
Rosenstiel Research Center, Brandeis University, Waltham, MA 02254-9110
6 shared publicationsBernard Hoflack
2 shared publicationsC Jamieson
Rosenstiel Research Center, Brandeis University, Waltham, MA 02254-9110
2 shared publications- Guillaume Caulier
Institut de Génétique et de Biologie Moléculaire et cellulaire (IGBMC), Centre National de Recherche scientifique (CNRS) UMR 7104 - Institut National de santé et de Recherche Médicale (Inserm) U964 - Université de Strasbourg, 1 rue Laurent Fries, Illkirch, France
2 shared publications M Yoshida
Rosenstiel Research Center, Brandeis University, Waltham, MA 02254-9110
2 shared publications
Latest Publications
- Open Access
Direct monitoring of unfolded nascent polypeptides by the CCR4-NOT complex contributes to protein quality control through selective mRNA deadenylation and decay
Accumulation of aberrant and unfolded proteins induce cellular stresses and contributes in human to diseases and aging. Several cellular pathways combat the formation of these deleterious molecules. Recently, processes limiting the production of unwanted polypeptides through the co-translational degradation of their messenger RNAs (mRNAs) have been identified but remain poorly understood. In Saccharomyces cerevisiae , Caf130 was proposed to regulate the levels of mRNAs encoding some ribosomal proteins, principally Rpl4, when they do not fold properly. We report the functional and structural characterization this process. Biochemical purifications, interaction assays, and in vivo analyses combined with Alphafold modelling define the organization and function of the Caf130 module of the CCR4-NOT complex and associated factors that mediate this process. Our data reveal the critical role of different forms of the Nascent protein Associated Complex (NAC) to dock the CCR4-NOT complex onto translating ribosomes. The CCR4-NOT complex directly recognizes some nascent unfolded proteins emerging from the ribosome tunnel triggering deadenylation of the mRNAs encoding them. Our data further reveal unsuspected evolutionary and functional similarities between yeast and mammalian proteins involved in the quality control of nascent proteins through mRNA degradation. Altogether, our data indicate the existence of a conserved machinery contributing to protein quality control by triggering the decay of mRNAs encoding deleterious polypeptides in eukaryotes.
Open AccessDirect monitoring of unfolded nascent polypeptides by the CCR4-NOT complex contributes to protein quality control through selective mRNA deadenylation and decay
Accumulation of aberrant and unfolded proteins induce cellular stresses and contributes in human to diseases and aging. Several cellular pathways combat the formation of these deleterious molecules. Recently, processes limiting the production of unwanted polypeptides through the co-translational degradation of their messenger RNAs (mRNAs) have been identified but remain poorly understood. In Saccharomyces cerevisiae , Caf130 was proposed to regulate the levels of mRNAs encoding some ribosomal proteins, principally Rpl4, when they do not fold properly. We report the functional and structural characterization this process. Biochemical purifications, interaction assays, and in vivo analyses combined with Alphafold modelling define the organization and function of the Caf130 module of the CCR4-NOT complex and associated factors that mediate this process. Our data reveal the critical role of different forms of the Nascent protein Associated Complex (NAC) to dock the CCR4-NOT complex onto translating ribosomes. The CCR4-NOT complex directly recognizes some nascent unfolded proteins emerging from the ribosome tunnel triggering deadenylation of the mRNAs encoding them. Our data further reveal unsuspected evolutionary and functional similarities between yeast and mammalian proteins involved in the quality control of nascent proteins through mRNA degradation. Altogether, our data indicate the existence of a conserved machinery contributing to protein quality control by triggering the decay of mRNAs encoding deleterious polypeptides in eukaryotes.
- Open Access
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
The CCR4–NOT complex: a multifaceted sensor of molecular signals instructing eukaryotic mRNA translation and stability
The CCR4–NOT complex is a multi-subunit assembly found in all eukaryotic cells. Yet, its composition varies across organisms, with a universally conserved core enriched by lineage-specific subunits. Further, heterogeneity results from the occurrence of paralogous proteins, substoichiometric subunits, transient partners, and protein isoforms. Altogether, multiple CCR4–NOT complexes exist, and some even coexist within a single cell. The CCR4–NOT complex is an essential actor of gene expression through its roles in messenger RNA (mRNA) deadenylation, decay, and translation. Over time, support for the originally proposed role of the CCR4–NOT complex in transcription has been waning. Consistent with a role in post-transcriptional regulation, ribosomes appear to be major partners of the CCR4–NOT complex to coordinate translation and mRNA decay. Further, the CCR4–NOT complex is at the center of a network involving RNA-binding proteins and ubiquitin ligases, as well as factors of currently unknown function. Structural and functional analyses indicate that the CCR4–NOT complex integrates different levels of information present in mRNAs to control their stability and translation, thereby contributing to diverse functions including intricate processes such as human brain or pancreas development. It is thus not surprising that genetic alteration of this essential cellular machine, or impairment of its activity by pathogens, contributes to human diseases.
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
Open AccessThe CCR4–NOT complex: a multifaceted sensor of molecular signals instructing eukaryotic mRNA translation and stability
The CCR4–NOT complex is a multi-subunit assembly found in all eukaryotic cells. Yet, its composition varies across organisms, with a universally conserved core enriched by lineage-specific subunits. Further, heterogeneity results from the occurrence of paralogous proteins, substoichiometric subunits, transient partners, and protein isoforms. Altogether, multiple CCR4–NOT complexes exist, and some even coexist within a single cell. The CCR4–NOT complex is an essential actor of gene expression through its roles in messenger RNA (mRNA) deadenylation, decay, and translation. Over time, support for the originally proposed role of the CCR4–NOT complex in transcription has been waning. Consistent with a role in post-transcriptional regulation, ribosomes appear to be major partners of the CCR4–NOT complex to coordinate translation and mRNA decay. Further, the CCR4–NOT complex is at the center of a network involving RNA-binding proteins and ubiquitin ligases, as well as factors of currently unknown function. Structural and functional analyses indicate that the CCR4–NOT complex integrates different levels of information present in mRNAs to control their stability and translation, thereby contributing to diverse functions including intricate processes such as human brain or pancreas development. It is thus not surprising that genetic alteration of this essential cellular machine, or impairment of its activity by pathogens, contributes to human diseases.
- 13 October 2023
- Published by Springer Nature
- Vol. 2723, 113-123
An RNA-Ligation-Based RACE-PAT Assay to Monitor Poly(A) Tail Length of mRNAs of Interest
In eukaryotes, a non-templated poly-adenosine (poly(A)) tail is added co-transcriptionally to almost every messenger RNA (mRNA). The length of this poly(A) tail changes during the lifetime of mRNAs and has been shown in many circumstances to be an important factor controlling transcript fates. Yet, the measure of the length of this homogenous nucleotide sequence is technically challenging, making it difficult to assess its dynamic variation. In this chapter, we describe an RNA-ligation-based RACE-PAT (Rapid Amplification of cDNA End—Poly(A) Tail) assay to monitor the poly(A) tail length of mRNAs. In the first step, an RNA oligonucleotide is ligated to mRNA 3′ ends providing an anchoring site to prime cDNA synthesis, avoiding the bias introduced by oligo(dT)-derived primers. Afterward, reverse transcription is performed with an anchor primer with a unique 5′ extension. The choice of the oligonucleotide 3′ end at this step allows further flexibility to amplify modified tails, for example, by uridylation. Next, short DNA fragments encompassing the poly(A) tails are amplified by Polymerase Chain Reaction (PCR) using as forward primer, a transcript-specific primer hybridizing close to the transcript polyadenylation signal, and as reverse primer, an oligonucleotide corresponding to the 5′ extension of the primer used for cDNA synthesis, ensuring that only cDNAs are amplified. The resulting DNA fragments are then visualized after size fractionation by electrophoresis. This method does not provide exact nucleotide count and composition but has the advantage of allowing the processing of many samples in parallel at a low cost. Key words Poly(A) tail Polyadenylation Deadenylation RT-PCR RNA ligation Uridylation
- 13 October 2023
- Published by Springer Nature
- Vol. 2723, 113-123
An RNA-Ligation-Based RACE-PAT Assay to Monitor Poly(A) Tail Length of mRNAs of Interest
In eukaryotes, a non-templated poly-adenosine (poly(A)) tail is added co-transcriptionally to almost every messenger RNA (mRNA). The length of this poly(A) tail changes during the lifetime of mRNAs and has been shown in many circumstances to be an important factor controlling transcript fates. Yet, the measure of the length of this homogenous nucleotide sequence is technically challenging, making it difficult to assess its dynamic variation. In this chapter, we describe an RNA-ligation-based RACE-PAT (Rapid Amplification of cDNA End—Poly(A) Tail) assay to monitor the poly(A) tail length of mRNAs. In the first step, an RNA oligonucleotide is ligated to mRNA 3′ ends providing an anchoring site to prime cDNA synthesis, avoiding the bias introduced by oligo(dT)-derived primers. Afterward, reverse transcription is performed with an anchor primer with a unique 5′ extension. The choice of the oligonucleotide 3′ end at this step allows further flexibility to amplify modified tails, for example, by uridylation. Next, short DNA fragments encompassing the poly(A) tails are amplified by Polymerase Chain Reaction (PCR) using as forward primer, a transcript-specific primer hybridizing close to the transcript polyadenylation signal, and as reverse primer, an oligonucleotide corresponding to the 5′ extension of the primer used for cDNA synthesis, ensuring that only cDNAs are amplified. The resulting DNA fragments are then visualized after size fractionation by electrophoresis. This method does not provide exact nucleotide count and composition but has the advantage of allowing the processing of many samples in parallel at a low cost. Key words Poly(A) tail Polyadenylation Deadenylation RT-PCR RNA ligation Uridylation
- Open Access
- 30 December 2022
- Published by Elsevier in Cell Reports
- Vol. 42 (1) , 111902
The human CNOT1-CNOT10-CNOT11 complex forms a structural platform for protein-protein interactions
- 30 December 2022
- Published by Elsevier in Cell Reports
- Vol. 42 (1) , 111902
Open AccessThe human CNOT1-CNOT10-CNOT11 complex forms a structural platform for protein-protein interactions
- Open Access
- 1 June 2021
- Published by Taylor & Francis in RNA Biology
- Vol. 18 (12) , 2450-2465
A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation
Antiproliferative BTG/Tob proteins interact directly with the CAF1 deadenylase subunit of the CCR4-NOT complex. This binding requires the presence of two conserved motifs, boxA and boxB, characteristic of the BTG/Tob APRO domain. Consistently, these proteins were shown to stimulate mRNA deadenylation and decay in several instances. Two members of the family, BTG1 and BTG2, were reported further to associate with the protein arginine methyltransferase PRMT1 through a motif, boxC, conserved only in this subset of proteins. We recently demonstrated that BTG1 and BTG2 also contact the first RRM domain of the cytoplasmic poly(A) binding protein PABPC1. To decipher the mode of interaction of BTG1 and BTG2 with partners, we performed nuclear magnetic resonance experiments as well as mutational and biochemical analyses. Our data demonstrate that, in the context of an APRO domain, the boxC motif is necessary and sufficient to allow interaction with PABPC1 but, unexpectedly, that it is not required for BTG2 association with PRMT1. We show further that the presence of a boxC motif in an APRO domain endows it with the ability to stimulate deadenylation in cellulo and in vitro. Overall, our results identify the molecular interface allowing BTG1 and BTG2 to activate deadenylation, a process recently shown to be necessary for maintaining T-cell quiescence. GRAPHICAL ABSTRACT
- 1 June 2021
- Published by Taylor & Francis in RNA Biology
- Vol. 18 (12) , 2450-2465
Open AccessA conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation
Antiproliferative BTG/Tob proteins interact directly with the CAF1 deadenylase subunit of the CCR4-NOT complex. This binding requires the presence of two conserved motifs, boxA and boxB, characteristic of the BTG/Tob APRO domain. Consistently, these proteins were shown to stimulate mRNA deadenylation and decay in several instances. Two members of the family, BTG1 and BTG2, were reported further to associate with the protein arginine methyltransferase PRMT1 through a motif, boxC, conserved only in this subset of proteins. We recently demonstrated that BTG1 and BTG2 also contact the first RRM domain of the cytoplasmic poly(A) binding protein PABPC1. To decipher the mode of interaction of BTG1 and BTG2 with partners, we performed nuclear magnetic resonance experiments as well as mutational and biochemical analyses. Our data demonstrate that, in the context of an APRO domain, the boxC motif is necessary and sufficient to allow interaction with PABPC1 but, unexpectedly, that it is not required for BTG2 association with PRMT1. We show further that the presence of a boxC motif in an APRO domain endows it with the ability to stimulate deadenylation in cellulo and in vitro. Overall, our results identify the molecular interface allowing BTG1 and BTG2 to activate deadenylation, a process recently shown to be necessary for maintaining T-cell quiescence. GRAPHICAL ABSTRACT
- Open Access
- 25 February 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 10811
BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation
While BTG2 plays an important role in cellular differentiation and cancer, its precise molecular function remains unclear. BTG2 interacts with CAF1 deadenylase through its APRO domain, a defining feature of BTG/Tob factors. Our previous experiments revealed that expression of BTG2 promoted mRNA poly(A) tail shortening through an undefined mechanism. Here we report that the APRO domain of BTG2 interacts directly with the first RRM domain of the poly(A)-binding protein PABPC1. Moreover, PABPC1 RRM and BTG2 APRO domains are sufficient to stimulate CAF1 deadenylase activity in vitro in the absence of other CCR4–NOT complex subunits. Our results unravel thus the mechanism by which BTG2 stimulates mRNA deadenylation, demonstrating its direct role in poly(A) tail length control. Importantly, we also show that the interaction of BTG2 with the first RRM domain of PABPC1 is required for BTG2 to control cell proliferation.
- 25 February 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 10811
Open AccessBTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation
While BTG2 plays an important role in cellular differentiation and cancer, its precise molecular function remains unclear. BTG2 interacts with CAF1 deadenylase through its APRO domain, a defining feature of BTG/Tob factors. Our previous experiments revealed that expression of BTG2 promoted mRNA poly(A) tail shortening through an undefined mechanism. Here we report that the APRO domain of BTG2 interacts directly with the first RRM domain of the poly(A)-binding protein PABPC1. Moreover, PABPC1 RRM and BTG2 APRO domains are sufficient to stimulate CAF1 deadenylase activity in vitro in the absence of other CCR4–NOT complex subunits. Our results unravel thus the mechanism by which BTG2 stimulates mRNA deadenylation, demonstrating its direct role in poly(A) tail length control. Importantly, we also show that the interaction of BTG2 with the first RRM domain of PABPC1 is required for BTG2 to control cell proliferation.
- 1 June 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1829 (6-7) , 491-513
Intracellular ribonucleases involved in transcript processing and decay: Precision tools for RNA
- 1 June 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1829 (6-7) , 491-513
Intracellular ribonucleases involved in transcript processing and decay: Precision tools for RNA
- Open Access
- 1 February 2013
- Published by Taylor & Francis in RNA Biology
- Vol. 10 (2) , 267-276
C2ORF29/CNOT11 and CNOT10 form a new module of the CCR4-NOT complex
The CCR4-NOT complex was originally identified and its composition and organization characterized in the yeast Saccharomyces cerevisiae. It was first suggested to participate in transcription regulation, but since then it has become clear that it plays a key role in mRNA decay in all eukaryotes, thereby contributing importantly to gene expression regulation. Hence, the mammalian CCR4-NOT complex was recently shown to participate in miRNA-mediated mRNA repression. A better characterization of the composition and organization of this complex in higher eukaryotes is thus warranted. Purifications of the CCR4-NOT complex, performed by others and us, suggest that the protein of unknown function C2ORF29 is associated with this assembly. We demonstrate here that C2ORF29 is indeed a bona fide subunit of the human CCR4-NOT complex and propose to rename it CNOT11. In addition, we show that CNOT11 interacts with the first amino acids of CNOT1 and with CNOT10 and is required for the association of CNOT10 with the CCR4-NOT complex. Thus, the human CCR4-NOT complex possesses in addition to the CCR4-CAF1 deadenylase module and to the NOT module, a module composed of CNOT10 and CNOT11 that interacts with the N-terminal part of CNOT1. Phylogenetic analyses indicate that the CNOT10/CNOT11 module is conserved in all eukaryotes except fungi.
- 1 February 2013
- Published by Taylor & Francis in RNA Biology
- Vol. 10 (2) , 267-276
Open AccessC2ORF29/CNOT11 and CNOT10 form a new module of the CCR4-NOT complex
The CCR4-NOT complex was originally identified and its composition and organization characterized in the yeast Saccharomyces cerevisiae. It was first suggested to participate in transcription regulation, but since then it has become clear that it plays a key role in mRNA decay in all eukaryotes, thereby contributing importantly to gene expression regulation. Hence, the mammalian CCR4-NOT complex was recently shown to participate in miRNA-mediated mRNA repression. A better characterization of the composition and organization of this complex in higher eukaryotes is thus warranted. Purifications of the CCR4-NOT complex, performed by others and us, suggest that the protein of unknown function C2ORF29 is associated with this assembly. We demonstrate here that C2ORF29 is indeed a bona fide subunit of the human CCR4-NOT complex and propose to rename it CNOT11. In addition, we show that CNOT11 interacts with the first amino acids of CNOT1 and with CNOT10 and is required for the association of CNOT10 with the CCR4-NOT complex. Thus, the human CCR4-NOT complex possesses in addition to the CCR4-CAF1 deadenylase module and to the NOT module, a module composed of CNOT10 and CNOT11 that interacts with the N-terminal part of CNOT1. Phylogenetic analyses indicate that the CNOT10/CNOT11 module is conserved in all eukaryotes except fungi.
- 1 December 2009
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 34 (12) , 640-647
BTG/TOB factors impact deadenylases
- 1 December 2009
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 34 (12) , 640-647
BTG/TOB factors impact deadenylases
- Open Access
- 13 March 2008
- Published by Springer Nature in The EMBO Journal
- Vol. 27 (7) , 1039-1048
The BTG2 protein is a general activator of mRNA deadenylation
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 13 March 2008
- Published by Springer Nature in The EMBO Journal
- Vol. 27 (7) , 1039-1048
Open AccessThe BTG2 protein is a general activator of mRNA deadenylation
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.